Browsing: obesity

Investing.com — Weight-loss medications like the popular versions made by Denmark’s Novo Nordisk A/S (CSE:) and US peer Eli Lilly (NYSE:)…

By Farah Master and Andrew Silver HONG KONG/SHANGHAI (Reuters) – As China builds fewer houses and bridges, its consumers buy…

By Deena Beasley (Reuters) -Amgen on Tuesday said its second-quarter profit slipped 1% as higher expenses, including costs related to…

With weight-loss drugs like WeGovy and Ozempic dominating many of today’s consumer healthcare conversations, there’s a mounting concern for a…

By Patrick Wingrove (Reuters) -Eli Lilly said on Friday it has invested another $5.3 billion in its new Lebanon, Indiana…

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time…

In a recent earnings call, Zealand Pharma (NASDAQ:), a biotechnology company focused on the development of peptide-based medicines, reported a…